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Abstract
Cell penetrating peptides, also known as protein transduction domains, have the capacity to
ubiquitously cross cellular membranes carrying many different cargos with negligible cyto-
toxicity. As a result, they have emerged as a powerful tool for macromolecular delivery-
based therapies. In this study, catalytically active bacterial Ferredoxin-NADP+ reductase
(LepFNR) and Heme oxygenase (LepHO) fused to the HIV TAT-derived protein transduc-
tion peptide (TAT) were efficiently transduced to neuroblastoma SHSY-5Y cells. Proteins
entered the cells through an endocytic pathway showing a time/concentration dependent
mechanism that was clearly modulated by the nature of the cargo protein. Since ferredoxin-
NADP+ reductases and heme oxygenases have been implicated in mechanisms of oxidative
stress defense, neuroblastoma cells simultaneously transduced with TAT-LepFNR and
TAT-LepHO were challenged by H2O2 incubations to judge the cytoprotective power of
these bacterial enzymes. Accumulation of reactive oxygen species was significantly
reduced in these transduced neuronal cells. Moreover, measurements of metabolic viability,
membrane integrity, and cell survival indicated that these cells showed a better tolerance to
oxidative stress. Our results open the possibility for the application of transducible active
redox proteins to overcome the damage elicited by oxidative stress in cells and tissues.
Introduction
Plasma and organelle membranes of eukaryotic cells constitute rigorous barriers that selec-
tively control the movement of substances. Most of the exogenous compounds that could
endanger the essential cell homeostasis are impermeable under physiological conditions. Nev-
ertheless, these fences hamper the vast majority of hydrophilic drugs to reach their target mole-
cules inside the cell. Many transcription factors, enzymes, peptides, small interfering RNAs
(siRNAs) and oligonucleotides have become very attractive targets for overcoming different
diseases and malignancies. Nevertheless, they all require delivery strategies to circumvent the
membrane obstacle [1]. There are a variety of delivery techniques that include microinjection,
electroporation or liposome transfection and the use of viral based vectors. However, more
robust and safer uptake alternatives are unfortunately still lacking.
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Promising approaches to delivering macromolecules into cells emerged almost 30 years ago
from two unexpected findings: the HIV TAT transactivating factor [2,3] and the Drosophila
Antennapedia transcription factor [4] were shown to translocate cell membranes and enter
cells. The intriguing spontaneous uptake of both proteins led to structure/function studies to
find the minimal amino acid sequence required to support protein import. Therefore, it was
determined that TAT-PTD (TAT-Protein Transduction Domain), a short positively charged,
arginine-rich amino acid peptide, was the main contributor to HIV TAT protein transduction
[5]. Since then, these non-invasive vectors known as “cell penetrating peptides (CPPs)” or
“PTDs” have promoted numerous advances in macromolecular delivery-based therapies.
In recent years, several studies have given an indication of the wide delivery power of
TAT-PTD by showing the uptake of many different cargos (such as proteins, oligonucleotides,
nanoparticles and drugs) with low cytotoxicity in cultured cells and animal models [6–8]. Pro-
tein transduction often involves a three-step process: first, binding of the PTD to the cellular
membrane; second, stimulation of cellular uptake by endocytosis; and third, endosomal escape
of cargo into the cytoplasm [6,9]. Alternative internalization pathways, such as direct penetra-
tion of the membrane, have been proposed as well [10]. Evidence indicates that the route of
entry of arginine-rich peptides may differ according to the experimental conditions (e.g. pep-
tide concentration [11], cargo characteristics [12,13], etc.). Consequently, the precise mem-
brane translocation mechanism is still a matter of controversial debate.
Reactive oxygen species (ROS) management became central for every living organism on
earth. Oxidative metabolism requires a very fine tuning to guarantee cell homeostasis, limiting
ROS formation and regulating antioxidant defenses. Oxidative stress implies that this balance
has been altered or lost, leading to the overproduction of ROS and followed by internal cell
structure damage.
Neurons are particularly vulnerable to oxidative stress since they exhibit higher oxygen con-
sumption compared to other tissues and contain highly peroxidizable substrates. Moreover,
they have a long-life span during which some of them, located in specific regions related to
motor activity, accumulate iron, a main contributor to ROS generation [14,15]. Furthermore,
the brain has lower antioxidant defenses when compared to other tissues, for example, nearly
10% of antioxidants found in the liver [16,17]. Therefore, exogenous antioxidant therapies are
considered a valuable approach in the prevention of neurodegeneration. Recently, research
conducted in human brain cortical neurons has revealed that TAT mediated transduction of
Peroxiredoxin 6 conferred resistance against oxidative stress inducers [18].
Ferredoxin-NADP(H) reductases (FNR, EC 1.18.1.2) integrate a family of monomeric
enzymes that contain noncovalently bound FAD as a prosthetic group. These flavoproteins
catalyze the reversible electron transfer between NADP(H) and electron carrier proteins like
ferredoxin or flavodoxin. FNR isoforms were found in every living organism that was exam-
ined in their quest, participating in a broad spectrum of redox reactions [19]. In addition to
their involvement in photosynthesis and other pathways of central metabolism, FNRs have
been previously investigated as likely tools to mitigate the effect of oxidative stress [20–22].
Heme oxygenases (HO) are evolutionarily conserved enzymes that catabolize heme into equi-
molar amounts of labile Fe, carbon monoxide, and biliverdin. Heme, the substrate of HO,
exists essentially as a prosthetic group of hemoproteins as a resource that allows the incorpo-
ration of Fe2+ into proteins. Free heme is a dangerous agent inside the cell as it can catalyze the
production of aggressive ROS through the Fenton reaction [23]. Under homeostasis this effect
is strictly controlled by the binding of heme into the heme pockets of hemoproteins. However,
under oxidative stress, some hemoproteins can release their heme prosthetic groups, produc-
ing free heme. HOs are thought to protect against various types of oxidative stress, as
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previously described in detail [24]. Additionally, the products of HO activity are biologically
active molecules that possess diverse antioxidant effects.
In pathogenic microorganisms, HOs are involved in the iron acquisition from the host
heme during infection [25] and on the protection of the pathogen against heme toxicity [26].
Previous work from our group has demonstrated that HO from Leptospira interrogans
(LepHO), a parasitic bacterium that infects humans and causes leptospirosis, is able to bind
and efficiently catalyze the cleavage of heme to free iron and biliverdin. More interestingly,
LepHO uses a bacterium Ferredoxin NADP+ reductase (LepFNR) and NADPH as the sole
electron source. This enzyme pair is highly stable, quite unique and extremely efficient, and
will degrade heme to biliverdin in solution with the only requirement of NADPH, a substrate
readily available in the cellular cytoplasm and in the organelles [27]. Consequently, we hypoth-
esized that the delivery of this redox pair into cells during an oxidative stress challenge may
provide the defense reinforcement that, for particularly vulnerable cells like neurons, could
mean the chances of survival.
In this study, TAT fusions to LepFNR and LepHO expressed in E. coli proved to be capable
of degrading heme to biliverdin in vitro. Both fusion proteins efficiently transduced human
neuroblastoma cells (SHSY-5Y) in culture in a time/concentration-related fashion. Moreover,
transduction mediated by TAT-PTD was clearly modulated by the cargo protein and showed
indication of an endocytic entry pathway. This redox pair could simultaneously translocate
neuronal cells and generate a cytoprotective effect in response to oxidative stress in vitro.
Materials and methods
Construction of expression vectors
The genes encoding LepHO and LepFNR from L. interrogans serovar Lai 56601 were amplified
from a pET-TEV vector harboring the LepHO sequence [27] and the plasmid pET32JO--
LepFNR [28] using the oligonucleotides depicted in the S1 Table. Oligonucleotide sequences
were designed to introduce BamHI and HindIII (LepHO) and BamHI and SacI (LepFNR)
restriction enzymes sites at the 5’ and 3’ ends, respectively. The expression plasmids were con-
structed by inserting the amplification products previously cut with the indicated enzymes,
into the similarly restricted pET-TEV plasmid. To obtain the TAT fused proteins, two oligonu-
cleotides were synthesized and annealed to generate a double-stranded oligonucleotide encod-
ing 11 amino acids from the basic domain of HIV-1 TAT (YGRKKRRQRRR) and NdeI and
BamHI restriction sites at 5’ and 3’ ends respectively (S1 Table). The double-stranded oligonu-
cleotides were ligated into NdeI-BamHI–digested pET-TEV vector in frame with a 6 His
open-reading frame to generate pHisTAT-LepHO and pHisTAT-LepFNR.
Protein expression and purification
His-Tag LepHO/TAT-LepHO and LepFNR/TAT-LepFNR were expressed and purified essen-
tially as reported previously [27,28]. The purified protein was stored at −80˚C until used.
TAT-LepFNR/TAT-LepHO electron transfer reaction
Heme turnover was spectrophotometrically determined as described before. Measurements
were carried out in 600 μl of 25 mM HEPES-KOH (pH 7.5) at 25˚C in a cell with 1 cm path
length. Reaction mixture contained 6 μM TAT-LepHO, 0.1 mg/mL catalase (Sigma), 3 mM
glucose 6-phosphate, 300 μM NADP+, 1 unit/mL glucose-6-phosphate dehydrogenase and
0.5 μM TAT-LepFNR. Optical absorption spectra were obtained using a Shimadzu UV-2450
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spectrophotometer. Spectral changes between 300 and 800 nm were monitored over a 30 min
time period. Biliverdin formation was followed using the absorbance change at 680 nm [27].
Transduction of fusion proteins into SH-SY5Y human neuroblastoma
cells
SH-SY5Y human neuroblastoma cells (ATCC CRL-2266) were maintained in Dulbecco’s
Modified Eagle’s Medium/Nutrient F-12 Ham (DMEM-F12) (Gibco) containing 10% fetal
bovine serum (FBS), and antibiotics (100 mg/mL streptomycin, 100 U/mL penicillin) at 37˚C
in a humidified atmosphere of 95% air and 5% CO2. To study the transduction of TAT fused
proteins, 7.5 x 105 cells were seeded in 35 mm plates and cultured for 24 h. Monolayers of cells
were incubated for selected time intervals with TAT-fused proteins in serum-free DMEM-F12.
After treatment, cells were washed twice with PBS buffer and treated with trypsin (0.2% tryp-
sin, 0.25 mM EDTA) for 15 min to degrade unincorporated protein. Finally, cells were har-
vested by centrifugation (1000xg, 5 min) and pellets were resuspended in RIPA lysis buffer (50
mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.5% Trito´n X-100, 0.5% Sodium deoxycholate, 0.1%
SDS) with protease inhibitors benzamidine (1 mM) and PMSF (1 mM).
Western blot analysis
Cell extracts were prepared by two rounds of sonication with a biorruptorTM (Diagenode,
UCD-200) followed by centrifugation at 12000xg for 20 min. Supernatant total protein con-
centration was determined using a Pierce BCA1 protein assay kit (Thermo Scientific). 50–60
µg of total protein were separated by 12% SDS-PAGE and transferred onto a nitrocellulose
membrane (Amersham) for Western blotting [29], using primary antibodies against LepHO
(1:750), LepFNR (1:100) raised in rabbits immunized with recombinant LepHO o LepFNR.
Antibodies against βIII-Tubulin (1:6000) were from Sigma, St. Louis, MO, USA. Subsequently,
blots were developed with a goat anti-rabbit phosphatase-conjugated IgG (Sigma, St. Louis,
MO, USA) and nitro-blue tetrazolium and 5-bromo-4-chloro-3’-indolyphosphate as chromo-
genic substrates.
Immunofluorescence and confocal microscopy
Cells were grown on glass coverslips in 35 mm plates for 24 h. After incubation with TAT-
fused proteins (3 μM) in serum-free DMEM-F12, cells were thoroughly washed 4 times with
PBS and fixed with 4% PFA-Sucrose in PBS for 30 min. Fixed cells were permeabilized with
0.2% Triton X-100 in PBS and subsequently blocked with 0.5% BSA in PBS for 1 h. Cells were
then incubated with rabbit anti-LepFNR (1:50) and anti-LepHO (1:200) antibodies for 1 h at
room temperature. The coverslips were washed, incubated 1 h at room temperature with the
secondary Alexa-488 conjugated anti-rabbit antibody (1:800, Life Technologies Corporation,
Carlsbad, CA, USA) and mounted with ProLong1 with DAPI. A sample was processed in
parallel omitting the primary antibody as a background control. Confocal images were
obtained using a Zeiss LSM 880 confocal microscope with a 20X objective. Zen image acquisi-
tion software (Carl Zeiss) was used to analyze images.
Metabolic viability assay
SH-SY5Y cells were seeded in 96-wells plates at a density of 3x104 cells/well in 100 μL serum-
free medium. Cells were treated with H2O2 (100 μM) for 6 h. Then, without removing the oxi-
dizing agent, TAT-LepHO and TAT-LepFNR (3 μM) were simultaneously added to the
medium and the cells incubated for a further 18 h, reaching a total incubation time of 24 h.
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Control cells were maintained in identical conditions without the addition of the fusion pro-
teins. At the end of the incubation time, culture media was replaced with 100 μL of 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and after 4 h the forma-
zan crystal produced was dissolved in DMSO and absorption at 540 nm was determined. Cell
viability was expressed as a percentage of control cells MTT reduction. Three wells per group
were assayed in each experiment.
Membrane integrity assay
Cell membrane integrity was evaluated through Lactate Dehydrogenase leakage into the cul-
ture medium using LDH activity reagent (0.6 mM Sodium pyruvate, 0.18 mM NADH, 50 mM
Sodium Phosphate Buffer (pH 7.5)). SH-SY5Y cells were seeded in 96-well plates at a density
of 3x104 cells/well in 100 μL serum-free medium. Cells were treated with H2O2 (100 μM) for 6
h. Then, without removing the oxidizing agent, TAT-LepHO and TAT-LepFNR (3 μM) were
simultaneously added to the medium and the cells incubated for a further 18 h, reaching a
total incubation time of 24 h. Control cells were maintained in identical conditions without
the addition of the fusion proteins. To calculate LDH activity, aliquots of media and warm
reagent were mixed in a 96-wells plate, and NADH absorbance decay was recorded at 340 nm
during 4 min at 30 s intervals using a microplate spectrophotometer system (Epoch, BioTek).
Data were express as a percentage of LDH release with respect to total LDH activity. Medium
of cells treated with RIPA buffer represented total LDH activity. Three wells per group were
assayed in each experiment.
Vital staining
SH-SY5Y cells in suspension (2x106) were simultaneously treated with TAT-LepHO and
TAT-LepFNR (3 μM) or left in serum-free medium for 1 h and then exposed to H2O2 (1 mM)
for another hour. Cell pellets were washed with PBS buffer and resuspended in 500 μL of stain-
ing medium (serum free DMEM-F12, 2 μg/mL Fluorescein Diacetate, 1.2 μg/mL Propidium
Iodide) during 5 min in a dark place at room temperature. Cells were washed with 1 mL PBS
buffer and resuspended in 200 μL PBS buffer. The cell suspension (10 μL) was placed on a
microscope coverslip and observed under a fluorescence microscope (Eclipse E800 microscope,
Nikon). Quantification was made using cell counting software (ImageJ) on 3 image fields of
each independent experiment. Images for quantification were taken with a 20X objective.
Measurement of intracellular ROS
SH SY5Y cells (7.5x105) were seeded in 35 mm culture plates and incubated 24 h in complete
medium. Cell monolayers were pre-treated for 2 h with H2O2 (500 μM). Then, the culture
medium was discarded, and cells were loaded with 2’,7’-dichlorofluorescein diacetate
(DCFH-DA, Sigma, St. Louis, MO, USA) (80 μM) for 30 min and subsequently washed with
PBS buffer. Cells were either incubated in serum-free medium alone or treated with TAT-
fused proteins (3 μM) plus Chloroquine (100 μM) for 1 h. After trypsinization, cells were
resuspended in PBS buffer and transferred to a black 96 wells plate to read fluorescence at 520
nm (excitation: 485 nm) in a microplate reader Synergy (Biotek). Three wells per group were
assayed in each experiment.
Statistics
Data were analyzed with GraphPad Prism 5.0 software package and expressed as mean ± SD,
experiments were performed in triplicate. These replicates were completely independent as
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they were done in different days, starting from different cell culture dishes. Statistical analyses
were performed using one-way ANOVA followed by the Tukey’s post hoc test for comparison
between means. Statistical significance was set at p< 0,05.
Results
Expression and purification of the LepHO and LepFNR variants
Expression system for the wild type and TAT fusion forms of LepHO and LepFNR were
designed (Fig 1A). All proteins were obtained in soluble and pure forms with good yields, as
judged by SDS-PAGE and Western blot analysis (Fig 1B).
Heme turnover was spectrophotometrically determined to confirm that TAT extension
does not alter electron transport between LepFNR/LepHO enzymes. Incubation of TAT-Le-
pHO with TAT-LepFNR and NADPH resulted in spectral changes that are consistent with the
formation of a ferrous dioxyheme complex [Heme(Fe2+)-O2] and the conversion of the latter
to biliverdin. These can be seen in the time-dependent decay of the 538 and 575 nm peaks (fer-
rous dioxyheme complex) and growth of a broad band at 680 nm (biliverdin) (Fig 2).
Characterization of TAT-LepHO and TAT-LepFNR transduction into
SH-SY5Y cells
Purified TAT-LepHO or TAT-LepFNR (1 μM) were added to the culture medium. Samples
were taken at various incubation times (15–90 min), and cells were exposed to trypsin to
degrade the extracellular membrane-bound TAT-fused proteins. Then, the amount of inter-
nalized proteins of each sample was determined by Western blotting using anti-LepHO,
LepFNR or βIII-Tubulin as a control. TAT-LepFNR was already detected inside the cells after
15 min of incubation. Uptake of this fusion protein was gradually increased up to 1 h of incu-
bation. Nonetheless, band signal began to drop when incubation time exceeded 1 h indicating
Fig 1. Protein design, expression and purification. (A) Schematic representation of wild type and TAT
fusion forms of LepHO and LepFNR. (B) Purified fractions of each recombinant loaded into 12% SDS-PAGE
and subsequently stained with Coomassie blue: lane 1, His-TAT-LepFNR (39.1 kDa); lane 2, His-LepFNR
(37.6 kDa); lane 3, His-LepHO (28.4 kDa); Lane 4, His-TAT-LepHO (29.9 kDa). (C) Western blot analysis of
purified products using primary antibodies anti-LepFNR and anti-LepHO raised in rabbits.
https://doi.org/10.1371/journal.pone.0184617.g001
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that the import occurs in a time limited window and that TAT-LepFNR has a limited stability
inside the cell. Conversely, TAT-LepHO uptake started at 15 min and kept rising throughout
the 90 min incubation (Fig 3A). We further analyzed TAT-fused protein transduction by test-
ing different protein concentration in the incubation media within 1 h of treatment (Fig 3B).
We observed that TAT-LepHO translocation increased with concentration in the range of
0.5–8 μM. Instead, when extracellular TAT-LepFNR concentration raised above 2 μM the
amount of internalized protein did not change, suggesting a saturable process.
To confirm the TAT-linked protein penetration to cytoplasm and to track their destination,
cells were incubated with TAT fusions of LepHO and LepFNR. Then, they were analyzed by
immunofluorescence with anti-LepFNR and anti-LepHO antibodies followed by confocal
laser scanning microscopy at different time points after the media was removed (Fig 4). We
observed that after 30 min, both TAT-fused proteins were detected in cells cytoplasm in a very
distinctive dotted pattern around the large nucleus of SH-SY5Y cells. At a longer time (60
min), however, some cells displayed areas of diffuse homogenous green pigmentation (white
arrows); meanwhile, the population of small green dots had diminished and was replaced by
larger ones, possibly as a result of the fusion of the smaller dots with each other. This might be
attributed to a vesicle-like endosomal entrance in agreement with previous studies [9].
The permanence of TAT-fused protein inside the cell was evaluated by 1 h cells incubation
with TAT-protein (3 μM) in serum free media followed by medium removal, cell wash and
further incubation in fresh DMEM-F12 for various time periods (Fig 5). We were able to
detect TAT-LepFNR by western blot in total extracts obtained from cells collected 1 h post-
Fig 2. Heme turnover by TAT-LepHO in the presence of TAT-LepFNR. Time dependent absorption
spectra of TAT-LepHO before (dotted line) and after the addition of 0.5 μM TAT-LepFNR in the presence of
300 μM NADPH and 0.1 mg/ml catalase recorded at 1 min intervals (solid lines). As the reaction proceeded,
the TAT-LepHO Soret peak at 403 nm decreased, and a broad absorption band with maximum near 680 nm
(biliverdin) appeared, indicating that TAT-LepHO channeled TAT-LepFNR electrons to cleave heme and
produce biliverdin. The inset shows an enlargement of the region between 500 and 800 nm.
https://doi.org/10.1371/journal.pone.0184617.g002
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incorporation, however, only traces of the imported protein were observed after 2 h. On the
other hand, TAT-LepHO showed greater stability when compared to TAT-LepFNR.
Many reports on TAT-PTD have pointed out that its entry mostly relies on endocytic path-
ways. An uptake decrease at low temperatures indicates that peptide internalization depends
on an active membrane mechanism. Fig 6 shows that cells incubated at 4˚C were not able to
incorporate either TAT-LepHO or TAT-LepFNR, implicating that internalization of these
macromolecules is a process that depends on plasma membrane fluidity. On the other hand,
an increase of the protein transduction efficiency caused by chloroquine provides evidence of
an endocytic route of entry. This endosomolytic reagent prolongs the fusion protein stability
and promotes endosomal escape by delaying the endosome/lysosome fusion. Increasing
Fig 3. Transduction of TAT-LepFNR and TAT-LepHO into SH-SY5Y cells. (A) Transduction time
dependence. SH-SY5Y cells were incubated with 1 μM TAT-LepFNR (white diamonds) or TAT-LepHO (black
circles) in serum free medium. Cell extracts were prepared at different time intervals and examined by
Western blot analysis. As a control, cells were incubated for 1 h with 1 μM Lep-FNR/Lep-HO. (B) Transduction
concentration dependence. SH-SY5Y cells were incubated for 1 h with TAT-LepFNR (white diamonds) or
TAT-LepHO (black circles) in serum free medium at stated concentration of each protein. Cell extracts were
prepared and examined by Western blot analysis. As a negative control, cells were incubated for 1 h with
3 μM Lep-FNR/Lep-HO. Band density was calculated relative to a loading control of βIII-tubulin. Images are
representative of 3 different experiments.
https://doi.org/10.1371/journal.pone.0184617.g003
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concentrations of chloroquine markedly enhanced TAT-LepFNR permanence inside the cells.
On the contrary, TAT-LepHO stability was virtually unchanged.
SH-SY5Y cells were incubated with both TAT-fused proteins to investigate the transduction
of each construct in the presence of the other. In this experiment, proteins were simulta-
neously added to the incubation medium, and cells were harvested after 1 or 2 h of treatment.
Fig 7 shows that both TAT constructs were able to translocate the cell membrane at the same
level they had done when they were individually added, implicating that they neither compete
nor exhibit synergistic effects on their mechanisms of entry. When incubation extended up to
2 h, the level of TAT-LepFNR was drastically diminished in concordance with the previous
experiments, indicating that TAT-LepHO has no effect on the internal stability of its co-trans-
duced partner. Additionally, proteins were added sequentially to establish if the previously
imported protein had any effect on the translocation of the other. Once again, it was demon-
strated that they had little or no effect on the import process of each and that TAT-LepFNR
permanence inside the cell is clearly shorter when compared to TAT-LepHO.
Fig 4. Immunofluorescence detection of transduced proteins. Cells were incubated with 3μM TAT-LepHO/TAT-LepFNR for
30–60 min using LepHO and LepFNR as negative controls, respectively. Fixed and permeabilized cells were then incubated with
primary anti-LepHO/LepFNR antibodies. The coverslips were washed, incubated with the secondary Alexa-488 conjugated
antibody, and mounted with ProLong with DAPI. White arrows show diffuse green fluorescent areas. Confocal images were
obtained using a Zeiss LSM 880 confocal microscope with a 20X objective. Magnification: scan zoom x:3, y:3, scale bar 10μm. Zen
image acquisition software (Carl Zeiss) was used to analyze images.
https://doi.org/10.1371/journal.pone.0184617.g004
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Oxidative stress protection by simultaneous incorporation of
TAT-LepFNR and TAT-LepHO
The yellow tetrazolium MTT is reduced by metabolically active cells to a purple formazan. As
previously stated, LepFNR and LepHO might work together in the prevention of oxidative
stress injury and thus, this would reflect in the rescue of the metabolic status of cells. The meta-
bolic viability of cells exposed to H2O2 (100 μM), as described in Material and methods, was
39.6 ± 1.6% of the control (p<0.001). However, when cells were additionally treated with
TAT-LepHO/FNR (3 μM-18 h), metabolic viability significantly increased to 64.16 ± 0.8%
(p<0.01) (Fig 8A). Assays of MTT reduction in cells treated with TAT-LepHO or
TAT-LepFNR individually were performed (S1 Fig). TAT-LepFNR yield only ca 6% protec-
tion. Previous results have shown protection of Cos-7 cells against ROS by transient transfor-
mation with a plasmid that expressed pea ferredoxin NADP+ reductase [22]. The treatment of
cells with TAT-LepHO displayed no significant differences with respect to the control.
To compare the efficiency of TAT-LepHO/FNR metabolic viability recovery with that pro-
duced by known natural antioxidants, vitamin C and E were analyzed. We found that vitamin
C and E provoked a recovery of ~14% and ~18% respectively. Likewise, cells transduced with
both fusion proteins displayed an ~22% protection (S2 Fig)
LDH release was evaluated as a marker of cytotoxicity induced by H2O2 exposure. Cells
incubated in the presence of H2O2 (100 μM), as described in Material and methods, displayed
Fig 5. TAT-fusion protein stability inside the cell. (A) SH-SY5Y cells were incubated with 3 μM
TAT-LepFNR or TAT-LepHO in a serum free medium for 1 h. The medium was removed and cells were
washed with PBS buffer before a fresh medium was added. Cell extracts were prepared at different time
intervals and examined by Western blot analysis. Representative blots of 3 different experiments are shown.
(B) Densitometric analysis of the transduced proteins. Protein levels were normalized to that of βIII-tubulin.
https://doi.org/10.1371/journal.pone.0184617.g005
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an LDH activity increase of 21.1 ± 1.5% (p<0.001) when compared to 8.1 ± 1.0% released by
the control group. When H2O2 treated cells were then incubated in medium containing
TAT-LepHO/FNR (3 μM), LDH leakage decreased to 19.2 ± 0.4% (p<0.05), showing a statisti-
cally significant difference (Fig 8B).
These experiments suggest that LepHO and LepFNR TAT-mediated internalization
resulted in a redox response enhancement that protected cells from oxidative stress damage.
Fluorescein Diacetate (FDA) is taken up by viable cells and enzymatically converted to the
green fluorescent metabolite fluorescein in an esterase dependent reaction. In contrast, the
nuclei staining dye Propidium Iodide (PI) only reaches the nucleus by passing dead cell mem-
branes, and intercalates with the DNA double helix giving a red fluorescent signal. As shown
in Fig 9, 68.8 ± 9.7% of the cells that had been exposed to growth media containing H2O2 (1
mM) were stained with FDA. Cells subjected to the same treatment displayed a 5.4-fold
increase of PI stained nucleus (541.5 ± 137.4%) when compared to control cells (p<0.01).
Then again, cells that were previously treated with TAT-LepHO/FNR (3 μM) for 1 h before
H2O2 exposure, presented an elevated occurrence of green FDA stained cells (81.7 ± 3.1%) and
decreased red PI stained nucleus (359.2 ± 44.2%) (p<0.01). The analyzed images indicated
that transduction of redox active proteins might confer cells better odds to overcome an oxida-
tive stress situation.
The 2’,7’–dichlorofluorescein diacetate (DCFH-DA) probe is able to diffuse into the cell
through the plasmatic membrane, being then deacetylated by cellular esterases to a nonfluores-
cent compound (DCFH), which is later oxidized to DCF (λ excitation = 498 nm; λ
Fig 6. Transduction temperature dependence and chloroquine effects on the stability of the imported
protein. (A) SH-SY5Y cells were incubated with 3 μM TAT-LepFNR or TAT-LepHO at 4˚C and 37˚C in a
serum free medium. After 1 h of transduction Chloroquine was added to a fresh medium and incubation
proceeded up to 2 h. Representative blots of 3 different experiments are shown. (B) Densitometric analysis of
the transduced proteins. Protein levels were normalized to that of βIII-tubulin.
https://doi.org/10.1371/journal.pone.0184617.g006
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emission = 522 nm) by hydroxyl, peroxyl and other ROS activity within the cell (Fig 10A) [30].
This method has been shown to be reliable and efficient for the quantitative evaluation of oxi-
dative stress in cells as well as in testing the efficacy of antioxidants [31].
Cells challenged with H2O2 (500 μM) for 2 h exhibited a 2.3-fold increment in DCF fluores-
cence (8428.1 ± 1095.8 RFU) relative to the control cells (3590.8 ± 521.2 RFU) (p<0.001). In
contrast, cells exposed to H2O2, and subsequently treated with active redox fusions of TAT
(3 μM), decreased DCF fluorescence readings to 5809.6 ± 304.0 RFU (p<0.01). These data
indicated that simultaneous internalization of TAT-LepFNR and TAT-LepHO contributed
to maintaining the redox balance, whereby diminishing ROS accumulation inside the cells
(Fig 10).
Discussion
The central role of cell membranes is to enable the exchange of information between the cell
and its environment and to contain the essential components while acting as a barrier that pro-
tect cells against external factors. They also participate in numerous metabolic processes that
are fundamental for cell survival. The membrane also imposes a serious obstacle for the import
of various exogenous therapeutic molecules into the cell. Therefore, delivery of potential thera-
peutic agents constitutes a significant challenge to overcome. The finding of naturally occur-
ring proteins that can enter cells, opened the door to a promising alternative in molecular
delivery. Nowadays, CPPs or PTDs are widely used as research tools, and clinical trials are test-
ing PTD-mediated delivery of macromolecular drugs in patients [32]. In the present study, we
have demonstrated that two TAT-fused functional enzymes from Leptospira interrogans could
Fig 7. TAT-LepFNR and TAT-LepHO simultaneous transduction. (A) SH-SY5Y cells were incubated with
each TAT-protein or both, as depicted, and cell extracts were prepared and examined by Western blot
analysis. *The incubations were done sequentially in the indicated order. As a control (C), cells were
incubated for 1 h with 1 μM Lep-FNR/Lep-HO (C). Representative blots of 3 different experiments are shown.
(B) Densitometric analysis of the transduced proteins. Protein levels were normalized to that of βIII-tubulin.
https://doi.org/10.1371/journal.pone.0184617.g007
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be translocated simultaneously into neuronal cells and, therefore, enhance their tolerance to
oxidative stress.
Fig 8. Rescue of cell viability after H2O2 exposure mediated by TAT-fused protein delivery. SH-SY5Y
cells were exposed to 100 μM H2O2 and treated with TAT-LepHO and TAT-LepFNR, as described in Material
and methods. Cell viability was measured as follows: (A) Metabolic viability. Culture media was replaced with
100 μL MTT solution and after 4 h, the formazan crystal produced was dissolved in DMSO and absorption at
540 nm was determined. Cell viability was expressed as percentage of control cells MTT reduction, n = 3.
***p<0.001 vs. CON (control) cells; ##p<0.01 vs. H2O2 alone treated cells. (B) LDH release. Aliquots of media
and reagent were mixed in a 96-well plate and NADH absorbance decay was recorded at 340 nm. Data were
expressed as a percentage of LDH released with respect to total LDH activity. The medium of cells treated
with RIPA buffer represented Total LDH activity, n = 3. ***p<0.001 vs. CON (control) cells; #p<0.05 vs. H2O2-
alone treated cells.
https://doi.org/10.1371/journal.pone.0184617.g008
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Transduction of the fusion proteins under study mediated by TAT-PTD
We demonstrated that purified TAT-fused proteins were active as they reduced heme to bili-
verdin in the presence of NADPH (Fig 2). Moreover, they were readily internalized by cells
after 15 min of incubation (Fig 3). TAT-LepFNR translocation as a function of its extracellular
concentration suggested a cooperative and saturable process that might fit a glycosaminogly-
can-mediated endocytosis mechanism. It is known that this import mechanism needs the
recruitment of specific membrane components which help in the translocation process into
the cell [10,33]. The turnover rate and availability of these membrane components could
explain the behavior of TAT-LepFNR translocation. On the other hand, TAT-LepHO showed
a linear relationship with time and did not reach an extracellular plateau concentration in our
experimental conditions, indicating that the entry mechanism may vary depending on the
cargo protein. Our transduction assays at 4˚C showed that both constructions failed to enter
cells at low temperature (Fig 6) suggesting that the uptake of the CPPs depends on a cellular
process related to endocytosis rather than a direct translocation mechanism. Correspondingly,
confocal images of cells incubated with the TAT-fused proteins showed a vesicle-like pattern
around the nucleus (Fig 4). Furthermore, internal cell stability of TAT-LepFNR was remark-
ably lower than that observed for TAT-LepHO (Fig 5), and was affected by chloroquine treat-
ment (Fig 6). Altogether, these results suggest that TAT-LepFNR could be internalized via an
endocytic mechanism and that endosomal escape is a crucial step for its efficient delivery.
Conversely, TAT-LepHO with a different chemical profile would exert its own particular
Fig 9. Vital staining FDA/PI showed increased H2O2 tolerance as a result of incubation with TAT-fused proteins.
SH-SY5Y cells in suspension (2 x 106) were simultaneously treated with 3 μM TAT-LepHO and TAT-LepFNR or left in
serum free medium for 1 h and then exposed to 1 mM H2O2 for another hour. Cell pellets were washed with PBS buffer
and resuspended in 500 μl of staining medium (serum free DMEM-F12, 2 μg/mL Fluorescein Diacetate, 1.2 μg/mL
Propidium Iodide). n = 3, quantification was made using cell counting software (ImageJ) on 3 image fields of each
independent experiment. *p<0.05 vs. CON (control) cells; **p<0.01 vs. CON (control) cells; #p<0.05 vs. H2O2 alone-
treated cells. Scale bar first column = 50 μm; scale bar second column = 20 μm.
https://doi.org/10.1371/journal.pone.0184617.g009
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interaction with membrane components explaining the discrepancies in the route of entry of
TAT-fusions. Conjugating a cargo to a PTD modifies the overall charge, size, and hydropathy
of the fusion, which will in turn define the character of the cell surface interaction, intracellular
traffic, and final destination in the host cell as reported previously [13]. Additionally, we tested
the simultaneous transduction of TAT-LepFNR and TAT-LepHO resulting in an effective
uptake of both proteins (Fig 7). Our experiments clearly depicted that the nature of the cargo
proteins influence the import mechanism mediated by PTDs as it has been reported before for
CPP labeled with different dyes [34]. Therefore, for every molecule that needs to be translo-
cated to the cytoplasm, CPP strategy should be carefully studied.
Evaluation of TAT-fused proteins in oxidative stress protection
When neuronal cells harboring both TAT-fused proteins were exposed to H2O2 treatments,
they showed a significantly reduced ROS accumulation and, therefore, a better tolerance to the
oxidative stress, assayed as cell viability (Figs 8 and 9).
We observed that the protection induced by TAT-LepHO/FNR transduction measured by
MTT reduction was higher than that determined by LDH release. It has been previously
reported that different cytotoxicity assays might differ in their sensitivity to toxic stimulus
[35]. ROS would damage cell components giving early signs of viability loss when testing MTT
reduction. On the other hand, membrane leakage will occur in later stages as it involves a
Fig 10. Intracellular ROS decrease mediated by TAT-fused protein delivery. (A) Strategy for reactive
oxygen species quantification using DCFH-DA probe. (B) Cell monolayers were pre-treated for 2 h with
500 μM H2O2. Medium was discarded and cells were loaded with 80 μM DCFH-DA (30 min) and washed.
Cells were either incubated in serum free medium alone or treated with 3 μM TAT fused proteins and 100 μM
Chloroquine (1 h). CQ represents a control where DCFH-DA loaded cells were subsequently incubated with
100 μM chloroquine alone. After trypsinization, cells were resuspended in PBS buffer and transferred to a
black 96 well plate to read fluorescence at 520 nm (excitation: 485 nm). n = 3. **p<0.01 vs. CON (control)
cells; ***p<0.001 vs. CON (control) cells; ##p<0.01 vs. H2O2 alone treated cells.
https://doi.org/10.1371/journal.pone.0184617.g010
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more profound damage to the cell. This could explain the fact that our treatment with H2O2
generates an important loss of MTT reduction capacity but a slight increase in LDH activity in
culture media of treated cells.
It is known that NADPH participates on the oxidative protection through a complex system
of metabolic response mechanisms [36]. An abnormal increase of NADPH level may be detri-
mental to cell survival. In yeast, it has been observed that NADPH accumulation is toxic for
cell growth [37], a phenomenon probably common in all eukaryotes [38]. Cellular aggression
by H2O2 generates important damage on enzymes involved in the NADPH metabolism and
thus may alter its intracellular level. In bacteria, it has been proposed that an elevated NADPH
concentration might have pro-oxidant effects by acting as an electron donor for the generation
of hydroxyl radicals (OH•) via a Fe2+-dependent Fenton reaction [39]. This process may occur
directly between the reduced pyridine nucleotide and the iron [40] or catalyzed by an enzyme
that exhibits ferric reductase activity [41] also present in human cells [42]. Moreover, abnor-
mal levels of NADPH could drive the generation of ROS by the NADPH oxidase. This enzyme
complex is known to produce O2
- and/or H2O2 during the transfer of redox equivalents from
cytosolic NADPH to molecular oxygen [43,44]. Thus, a possible explanation for the oxidative
stress tolerance conferred by LepFNR might be related with the previously reported role of
these flavoenzymes in reducing the NADPH intracellular concentration. FNR would prevent
NADPH accumulation by mediating the electron transfer from NADPH to a variety of elec-
tron acceptors, as observed in bacteria [20,21]. Moreover, the transduced enzyme pair would
have the capability to regulate the nucleotide level efficiently using the available cellular heme
without the need for other electron acceptors.
Heme accumulation inside the cell produces diverse types of damages in enzymes and
membranes which may drive to cell apoptosis. Then, by controlling its intracellular concentra-
tion, the damage can be mitigated [45]. The incorporation of the LepHO would produce an
immediate decrease of the population free heme. LepHO is one of the heme oxygenases show-
ing the highest affinity for heme, with a Kd for the prosthetic group of 17 nM [27]. Also,
LepFNR possesses the ability to provide the redox equivalents necessary to complete the degra-
dation of heme to biliverdin without the participation of any other auxiliary electron donors as
ascorbate or trolox. Free heme can be converted by the LepFNR-LepHO pair in carbon mon-
oxide and biliverdin with a concurrent release of Fe2+ which will induce the synthesis of ferri-
tin for iron sequestration [46]. Moreover, converting heme to Fe2+ allows the cell to export the
metal ion through the ferroportin [47], thus releasing the toxicity generated by heme or the
free iron.
The products of LepHO degradation of heme may have other protective effects. Both bili-
verdin and bilirubin possess potent antioxidant properties [48,49]. Carbon monoxide, like
nitric oxide, is a signal molecule and a gaseous modulator. It is involved in cytoprotective gene
up-regulation mainly based on its ability to interact with the heme groups of hemoproteins
[50]. It has also been reported a non-enzymatic signaling function for HO-1. This enzyme is
involved in the regulation of gene expression and in the modulation of protein translation
[51]. It has been shown that participates in a complex network of regulations, interacting with
DNA repair proteins and transcription factors as Nrf2 and STAT3 [51]. Nrf2 immunoreactive
fragment may have significant implications on oxidative stress gene regulation. Likewise,
STAT3 regulates cell proliferation, migration, and invasion [51] thus may influence the recov-
ery of cells under stress conditions. These effects may be adjusted by the cellular localization of
HO. It has been demonstrated that endogenous HO can be found in the endoplasmic reticu-
lum, mitochondria, caveolae and in the nucleus, as a full protein or as a inactive processed
form [52], indicating that protective functions may not only be related to its enzymatic
activity.
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In conclusion, we have provided evidence of a novel approach to preventing oxidative stress
damage to neuronal tissue through an evolutionarily conserved redox enzyme pair by making
use of TAT protein transduction domain.
Our observations allow us to suggest a potential use of this system in the protection of tis-
sues subjected to different stress conditions, such as ischemia, trauma, or surgery. Among the
advantages of this approach, it should be mentioned that, unlike tissue transformation, this
treatment could be applied transiently when needed, and then removed by the cell itself, leav-
ing no trace in the treated tissue.
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S1 Fig. Rescue of cell viability after H2O2 exposure mediated by TAT-LepHO,
TAT-LepFNR or the pair TAT-LepHO/TAT-LepFNR. SH-SY5Y cells were exposed to
100 μM H2O2 and treated with TAT-LepHO, TAT-LepFNR or the pair TAT-LepHO/
TAT-LepFNR as described in Material and methods. Metabolic viability was measured as fol-
lows: At the end of the 24 h incubation culture media was replaced with 100 μL MTT solution,
the formazan crystal produced after 4 h was dissolved in DMSO and absorption at 540 nm was
determined. Cell viability was expressed as percentage of control cells MTT reduction, n = 3.
p<0.001 vs. all H2O2 treated groups;
###p<0.001 vs. H2O2 alone and individually delivered
TAT-protein groups.
(TIF)
S2 Fig. Rescue of cell viability after H2O2 exposure mediated by vitamin C or Vitamin E,
and the pair TAT-LepHO/TAT-LepFNR. SH-SY5Y cells were exposed to 100 μM H2O2 and
treated with the pair TAT-LepHO/TAT-LepFNR, vitamin C or E as described in Material and
methods. Metabolic viability was measured as follows: At the end of the 24 h incubation cul-
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was dissolved in DMSO and absorption at 540 nm was determined. Cell viability was expressed
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(TIF)
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